Ana R Quiñones1,2, Sheila Markwardt3, Anda Botoseneanu4,5. 1. Department of Family Medicine, Oregon Health & Science University, Portland, OR, USA. quinones@ohsu.edu. 2. OHSU-PSU School of Public Health, Portland, OR, USA. quinones@ohsu.edu. 3. OHSU-PSU School of Public Health, Portland, OR, USA. 4. Department of Health & Human Services, University of Michigan, Dearborn, MI, USA. 5. Institute of Gerontology, University of Michigan, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Older adults with diabetes rarely have only one chronic disease. As a result, there is a need to re-conceptualize research and clinical practice to address the growing number of older Americans with diabetes and concurrent chronic diseases (diabetes-multimorbidity). OBJECTIVE: To identify prevalent multimorbidity combinations and examine their association with poor functional status among a nationally representative sample of middle-aged and older adults with diabetes. DESIGN: A prospective cohort study of the 2012-2014 Health and Retirement Study (HRS) data. We identified the most prevalent diabetes-multimorbidity combinations and estimated negative binomial models of diabetes-multimorbidity on prospective disability. PARTICIPANTS: Analytic sample included 3841 HRS participants with diabetes, aged 51 years and older. MAIN MEASURES: The main outcome measure was the combined activities of daily living (ADL)-instrumental activities of daily living (IADL) index (range 0-11; higher index denotes higher disability). The main independent variables were diabetes-multimorbidity combination groups, defined as the co-occurrence of diabetes and at least one of six somatic chronic diseases (hypertension, cardiovascular disease, lung disease, cancer, arthritis, and stroke) and/or two mental chronic conditions (cognitive impairment and high depressive symptoms (CESD score ≥ 4). KEY RESULTS: The three most prevalent multimorbidity combinations were, in rank-order diabetes-arthritis-hypertension (n = 694, 18.1%); diabetes-hypertension (n = 481, 12.5%); and diabetes-arthritis-hypertension-heart disease (n = 383, 10%). Diabetes-multimorbidity combinations that included high depressive symptoms or stroke had significantly higher counts of ADL-IADL limitations compared with diabetes-only. In head-to-head comparisons of diabetes-multimorbidity combinations, high depressive symptoms or stroke added to somatic multimorbidity combinations was associated with a higher count of ADL-IADL limitations (diabetes-arthritis-hypertension-high depressive symptoms vs. diabetes-arthritis-hypertension: IRR = 1.95 [1.13, 3.38]; diabetes-arthritis-hypertension-stroke vs. diabetes-arthritis-hypertension: IRR = 2.09 [1.15, 3.82]) even after adjusting for age, gender, education, race/ethnicity, BMI, baseline ADL-IADL, and diabetes duration. Coefficients were robust to further adjustment for diabetes treatment. CONCLUSIONS: Depressive symptoms or stroke added onto other multimorbidity combinations may pose a substantial functional burden for middle-aged and older adults with diabetes.
BACKGROUND: Older adults with diabetes rarely have only one chronic disease. As a result, there is a need to re-conceptualize research and clinical practice to address the growing number of older Americans with diabetes and concurrent chronic diseases (diabetes-multimorbidity). OBJECTIVE: To identify prevalent multimorbidity combinations and examine their association with poor functional status among a nationally representative sample of middle-aged and older adults with diabetes. DESIGN: A prospective cohort study of the 2012-2014 Health and Retirement Study (HRS) data. We identified the most prevalent diabetes-multimorbidity combinations and estimated negative binomial models of diabetes-multimorbidity on prospective disability. PARTICIPANTS: Analytic sample included 3841 HRSparticipants with diabetes, aged 51 years and older. MAIN MEASURES: The main outcome measure was the combined activities of daily living (ADL)-instrumental activities of daily living (IADL) index (range 0-11; higher index denotes higher disability). The main independent variables were diabetes-multimorbidity combination groups, defined as the co-occurrence of diabetes and at least one of six somatic chronic diseases (hypertension, cardiovascular disease, lung disease, cancer, arthritis, and stroke) and/or two mental chronic conditions (cognitive impairment and high depressive symptoms (CESD score ≥ 4). KEY RESULTS: The three most prevalent multimorbidity combinations were, in rank-order diabetes-arthritis-hypertension (n = 694, 18.1%); diabetes-hypertension (n = 481, 12.5%); and diabetes-arthritis-hypertension-heart disease (n = 383, 10%). Diabetes-multimorbidity combinations that included high depressive symptoms or stroke had significantly higher counts of ADL-IADL limitations compared with diabetes-only. In head-to-head comparisons of diabetes-multimorbidity combinations, high depressive symptoms or stroke added to somatic multimorbidity combinations was associated with a higher count of ADL-IADL limitations (diabetes-arthritis-hypertension-high depressive symptoms vs. diabetes-arthritis-hypertension: IRR = 1.95 [1.13, 3.38]; diabetes-arthritis-hypertension-stroke vs. diabetes-arthritis-hypertension: IRR = 2.09 [1.15, 3.82]) even after adjusting for age, gender, education, race/ethnicity, BMI, baseline ADL-IADL, and diabetes duration. Coefficients were robust to further adjustment for diabetes treatment. CONCLUSIONS: Depressive symptoms or stroke added onto other multimorbidity combinations may pose a substantial functional burden for middle-aged and older adults with diabetes.
Authors: Eric A Finkelstein; Jeremy W Bray; Hong Chen; Mary Jo Larson; Kay Miller; Christopher Tompkins; Allen Keme; Ronald Manderscheid Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Ana R Quiñones; Sheila Markwardt; Stephen Thielke; Ola Rostant; Elizabeth Vásquez; Anda Botoseneanu Journal: J Gerontol A Biol Sci Med Sci Date: 2018-01-16 Impact factor: 6.053
Authors: A Calderón-Larrañaga; J M Abad-Díez; L A Gimeno-Feliu; J Marta-Moreno; F González-Rubio; M Clerencia-Sierra; B Poblador-Plou; A Poncel-Falcó; A Prados-Torres Journal: Eur J Intern Med Date: 2015-03-10 Impact factor: 4.487
Authors: Charles C Chima; Jason L Salemi; Miranda Wang; Maria C Mejia de Grubb; Sandra J Gonzalez; Roger J Zoorob Journal: J Diabetes Complications Date: 2017-08-04 Impact factor: 2.852
Authors: Richard A Goodman; Samuel F Posner; Elbert S Huang; Anand K Parekh; Howard K Koh Journal: Prev Chronic Dis Date: 2013-04-25 Impact factor: 2.830
Authors: Christine Vogeli; Alexandra E Shields; Todd A Lee; Teresa B Gibson; William D Marder; Kevin B Weiss; David Blumenthal Journal: J Gen Intern Med Date: 2007-12 Impact factor: 5.128
Authors: Anda Botoseneanu; Sheila Markwardt; Corey L Nagel; Heather G Allore; Jason T Newsom; David A Dorr; Ana R Quiñones Journal: J Gerontol A Biol Sci Med Sci Date: 2022-02-03 Impact factor: 6.053